Press release
Seborrhoeic Dermatitis Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Arcutis Biotherapeutics, Cutanea Life Sciences, DermBiont, Astion Pharma
DelveInsight's, "Seborrhoeic Dermatitis - Pipeline Insight, 2025," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Seborrhoeic Dermatitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.According to DelveInsight, more than five key companies are actively engaged in developing over five treatment therapies for Seborrhoeic Dermatitis, highlighting ongoing efforts in this area.
Seborrhoeic Dermatitis Overview:
Seborrheic dermatitis is a long-term inflammatory skin disorder that mainly affects areas rich in sebaceous glands, such as the scalp, face, chest, back, armpits, and groin. It is estimated to impact about 4% of the population. Although the exact cause is not fully known, the condition is thought to be triggered by either an overgrowth of Malassezia-a normally harmless yeast present on the skin-or an exaggerated immune response to it. Diagnosis is usually made based on the rash's location and appearance, with skin biopsies rarely required. Treatment aims to lower yeast levels on the skin, commonly using medicated creams and shampoos that are generally safe for long-term use.
Request for a detailed insights report on Seborrhoeic Dermatitis pipeline insights @ https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
"Seborrhoeic Dermatitis Pipeline Insight 2025" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Seborrhoeic Dermatitis Therapeutics Market.
Key Takeaways from the Seborrhoeic Dermatitis Pipeline Report
*
DelveInsight's Seborrhoeic Dermatitis pipeline report depicts a robust space with 5+ active players working to develop 5+ pipeline therapies for Seborrhoeic Dermatitis treatment.
*
Key Seborrhoeic Dermatitis companies such as Arcutis Biotherapeutics, Cutanea Life Sciences, DermBiont, Astion Pharma A/S, Amorepacific, and others are evaluating new drugs for Seborrhoeic Dermatitis to improve the treatment landscape.
*
Promising Seborrhoeic Dermatitis pipeline therapies in various stages of development include Topical roflumilast foam (ARQ-154), Omiganan (CLS002), DBI-002, PAC-14028, and others.
*
Recent research has shown that seborrheic dermatitis has a unique immune profile, setting it apart from other skin conditions such as atopic dermatitis and plaque psoriasis. Additionally, disruptions in the skin barrier have been associated with alterations in specific gene expression patterns.
*
DermBiont has completed patient enrollment for a Phase 2b clinical trial evaluating SM-020 gel 1.0% for seborrheic keratoses, with topline results anticipated in the third quarter of 2024. If the outcomes are positive, the company may engage with the FDA to discuss the design of a potential Phase 3 trial.
*
The FDA has also approved roflumilast foam 0.3% (Zoryve) for the treatment of seborrheic dermatitis in patients aged 9 and older. This steroid-free, once-daily foam introduces a new treatment option for managing the condition.
Seborrhoeic Dermatitis Pipeline Analysis
The report provides insights into:
*
The report provides detailed insights into the key companies that are developing therapies in the Seborrhoeic Dermatitis Market.
*
The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Seborrhoeic Dermatitis treatment.
*
It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Seborrhoeic Dermatitis market.
Download our free sample page report on Seborrhoeic Dermatitis pipeline insights [https://www.delveinsight.com/sample-request/seborrhoeic-dermatitis-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Seborrhoeic Dermatitis Emerging Drugs
*
Topical roflumilast foam (ARQ-154): Arcutis Biotherapeutics
*
Omiganan (CLS002): Cutanea Life Sciences
*
DBI-002: DermBiont
*
PAC-14028: Amorepacific
Seborrhoeic Dermatitis Companies
More than five key companies are actively involved in developing treatments for seborrheic dermatitis. Among them, Arcutis Biotherapeutics and others have drug candidates currently in mid to advanced stages of development, particularly in Phase II clinical trials.
DelveInsight's report covers around 5+ products under different phases of clinical development like
*
Late stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I) along with the details of
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
Seborrhoeic Dermatitis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
*
Intravenous
*
Subcutaneous
*
Oral
*
Intramuscular
Seborrhoeic Dermatitis Products have been categorized under various Molecule types such as
*
Monoclonal antibody
*
Small molecule
*
Peptide
Download Sample Pages to Get an in-depth Assessment of the Emerging Seborrhoeic Dermatitis Therapies and Key Companies: Seborrhoeic Dermatitis Clinical Trials and advancements [https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Seborrhoeic Dermatitis Pipeline Therapeutic Assessment
- Seborrhoeic Dermatitis Assessment by Product Type
- Seborrhoeic Dermatitis By Stage
- Seborrhoeic Dermatitis Assessment by Route of Administration
- Seborrhoeic Dermatitis Assessment by Molecule Type
Download Seborrhoeic Dermatitis Sample report to know in detail about the Seborrhoeic Dermatitis treatment market @ Seborrhoeic Dermatitis Therapeutic Assessment [https://www.delveinsight.com/sample-request/seborrhoeic-dermatitis-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Table of Content
1. Report Introduction
2. Executive Summary
3. Seborrhoeic Dermatitis Current Treatment Patterns
4. Seborrhoeic Dermatitis - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Seborrhoeic Dermatitis Late-Stage Products (Phase-III)
7. Seborrhoeic Dermatitis Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Seborrhoeic Dermatitis Discontinued Products
13. Seborrhoeic Dermatitis Product Profiles
14. Seborrhoeic Dermatitis Key Companies
15. Seborrhoeic Dermatitis Key Products
16. Dormant and Discontinued Products
17. Seborrhoeic Dermatitis Unmet Needs
18. Seborrhoeic Dermatitis Future Perspectives
19. Seborrhoeic Dermatitis Analyst Review
20. Appendix
21. Report Methodology
Request the Sample PDF to Get Detailed Insights About the Seborrhoeic Dermatitis Pipeline Reports Offerings [https://www.delveinsight.com/sample-request/seborrhoeic-dermatitis-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=seborrhoeic-dermatitis-clinical-trials-companies-therapeutic-assessment-therapies-treatment-algorithm-pipeline-analysis-arcutis-biotherapeutics-cutanea-life-sciences-dermbiont-astion-pharma]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Seborrhoeic Dermatitis Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Arcutis Biotherapeutics, Cutanea Life Sciences, DermBiont, Astion Pharma here
News-ID: 4132314 • Views: …
More Releases from ABNewswire

Tokyo Portfolio Launches Tokyo's #1 Real Estate Platform for Global Buyers
150K+ social subscribers, 12M+ views, and 200K+ monthly pageviews power Tokyo's leading English portal for highend homes
Tokyo, Japan - August 29, 2025 - Tokyo Portfolio announced today that it has become Japan's mostwatched Englishlanguage brand focused on real estate, combining a large global audience with a highperforming listings portal for luxury rentals and purchases in Tokyo. The brand's videos and guides help expats and international buyers navigate one of the…

Floor Boys Introduces Premium Pet-Friendly Flooring Solutions for South Carolina …
Lexington-Based Flooring Specialist Offers Scratch-Resistant, Easy-Clean Flooring Options Perfect for Pet Owners
LEXINGTON, SC - Floor Boys Flooring Professionals, backed by 125+ years of combined experience serving Lexington and surrounding South Carolina communities, announces its expanded focus on pet-friendly flooring solutions designed specifically for homeowners with dogs, cats, and other pets. The company specializes in scratch-resistant luxury vinyl plank (LVP), waterproof carpet, tile, and hardwood alternatives that combine durability with style…

Top 6 Deck Builders In Kansas City For Stunning Outdoor Spaces
Outdoor living has evolved to become something more.
It is now a lifestyle choice.
Today's families seek spaces that harmonize with the natural world, yet remain as comfortable and well-designed as rooms in their homes. Patios and pergolas aren't an afterthought, but an absolute must that adds significant value to your property and makes everyday life better.
In areas with seasonal weather, where people can be outside for most of the year, homeowners…

Dash Capital Expands Zero Interest Business Loans in Detroit Following Unprecede …
Dash Capital's expansion in Detroit reflects strong demand from local businesses for flexible, fast funding solutions that support growth and operational needs across the Motor City's diverse economic landscape.
The Detroit business landscape continues to show remarkable resilience and growth potential, prompting Dash Capital to expand its funding programs in response to overwhelming demand from local entrepreneurs. This expansion comes at a time when Motor City businesses are actively seeking alternative…
More Releases for Seborrhoeic
Seborrhoeic Dermatitis Market Predicted to See Upsurge Through 2032, Highlights …
The Key Seborrhoeic Dermatitis Companies in the market include - Arcutis Biotherapeutics, Cutanea Life Sciences, Moberg Pharma AB, Astion Pharma A/S, LEO Pharma, Arcutis Biotherapeutics, Maruho Co., Ltd., Kamedis Ltd., Amorepacific Corporation, Moberg Pharma AB, Novartis, Incyte Corporation, and others.
DelveInsight's "Seborrhoeic Dermatitis Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Seborrhoeic Dermatitis, historical and forecasted epidemiology as well as the Seborrhoeic Dermatitis market trends in…
Seborrhoeic Dermatitis Market Growth to Accelerate in Forecast Period (2023-2032 …
The Key Seborrhoeic Dermatitis Companies in the market include - Arcutis Biotherapeutics, Cutanea Life Sciences, Moberg Pharma AB, Astion Pharma A/S, LEO Pharma, Arcutis Biotherapeutics, Maruho Co., Ltd., Kamedis Ltd., Amorepacific Corporation, Moberg Pharma AB, Novartis, Incyte Corporation, and others.
DelveInsight's "Seborrhoeic Dermatitis Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Seborrhoeic Dermatitis, historical and forecasted epidemiology as well as the Seborrhoeic Dermatitis market trends in…
Seborrhoeic Dermatitis Clinical Trials | A Drug Pipeline Analysis Report 2024 | …
DelveInsight's 'Seborrhoeic Dermatitis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Seborrhoeic Dermatitis therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Seborrhoeic Dermatitis pipeline domain.
Download our sample report @ https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Key Takeaways from the Seborrhoeic Dermatitis Pipeline Report
Over 5+ Seborrhoeic Dermatitis pipeline therapies are in various stages of development, and their…
Seborrhoeic Dermatitis Clinical Trials | A Drug Pipeline Analysis Report 2024 | …
DelveInsight's 'Seborrhoeic Dermatitis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Seborrhoeic Dermatitis therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Seborrhoeic Dermatitis pipeline domain.
Download our sample report @ https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Key Takeaways from the Seborrhoeic Dermatitis Pipeline Report
Over 5+ Seborrhoeic Dermatitis pipeline therapies are in various stages of development, and their…
Seborrhoeic Dermatitis Clinical Trials | A Drug Pipeline Analysis Report 2024 | …
DelveInsight's 'Seborrhoeic Dermatitis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Seborrhoeic Dermatitis therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Seborrhoeic Dermatitis pipeline domain.
Download our sample report @ https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Key Takeaways from the Seborrhoeic Dermatitis Pipeline Report
Over 5+ Seborrhoeic Dermatitis pipeline therapies are in various stages of development, and their…
Seborrhoeic Dermatitis Market to Witness Upsurge in Growth During the Forecast P …
The Seborrhoeic Dermatitis Market is anticipated to grow in the coming years owing to the potential launch of the pipeline therapiee, the rise in healthcare spending across the world, and the rise in the number of cases of Seborrhoeic Dermatitis in the 7MM. Key players, such as Arcutis Biotherapeutics, Cutanea Life Sciences, and others, are involved in developing drugs for Seborrhoeic Dermatitis.
DelveInsight's " [https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report delivers an in-depth understanding of…